Zhang, Xiao-Wei <br/><br/>
Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes.  [electronic resource] 

 -  Oncotarget  Feb 2017 
 - 9922-9934 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.14266  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Neutralizing--pharmacology<br/>Autophagy--drug effects<br/>Cell Line<br/>Chemical and Drug Induced Liver Injury--immunology<br/>Cholestasis--complications<br/>Cyclic S-Oxides--pharmacology<br/>Hepatocytes--drug effects<br/>Humans<br/>Interleukin-10--metabolism<br/>Interleukin-17--antagonists & inhibitors<br/>Liver--drug effects<br/>Liver Cirrhosis, Experimental--immunology<br/>Male<br/>Mice, Inbred BALB C<br/>Phosphorylation<br/>RNA Interference<br/>STAT3 Transcription Factor--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Th1 Cells--drug effects<br/>Thioacetamide<br/>Transfection